The role of peroxisome proliferator-activated receptors (PPAR) in immune responses

被引：368
作者：
Christofides, Anthos [1 ,2 ,3 ]
Konstantinidou, Eirini [1 ,2 ,3 ]
Jani, Chinmay [2 ,4 ]
Boussiotis, Vassiliki A. [1 ,2 ,3 ]
机构：
[1] Harvard Med Sch, Div Hematol Oncol, Boston, MA 02215 USA
[2] Harvard Med Sch, Dept Med, Boston, MA 02215 USA
[3] Harvard Med Sch, Ctr Canc, Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
[4] Mt Auburn Hosp, Dept Med, Cambridge, MA 02138 USA
来源：
METABOLISM-CLINICAL AND EXPERIMENTAL | 2021年 / 114卷
基金：
美国国家卫生研究院;
关键词：
PPAR; Metabolism; Inflammation; T cells; Myeloid cells; FATTY-ACID OXIDATION; REGULATE MACROPHAGE POLARIZATION; FOAM-CELL-FORMATION; RAT ADIPOSE-TISSUE; DELTA AGONIST; GENE-EXPRESSION; T-CELLS; MESSENGER-RNA; BETA/DELTA ACTIVATION; TRANSCRIPTION FACTOR;
D O I：
10.1016/j.metabol.2020.154338
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Peroxisome proliferator-activated receptors (PPARs) are fatty acid-activated transcription factors of nuclear hormone receptor superfamily that regulate energy metabolism. Currently, three PPAR subtypes have been identified: PPAR alpha, PPAR gamma, and PPAR beta/6. PPAR alpha and PPAR6 are highly expressed in oxidative tissues and regulate genes involved in substrate delivery and oxidative phosphorylation (OXPHOS) and regulation of energy homeostasis. In contrast, PPAR gamma is more important in lipogenesis and lipid synthesis, with highest expression levels in white adipose tissue (WAT). In addition to tissues regulating whole body energy homeostasis, PPARs are expressed in immune cells and have an emerging critical role in immune cell differentiation and fate commitment. In this review, we discuss the actions of PPARs in the function of the innate and the adaptive immune system and their implications in immune-mediated inflammatory conditions. (C) 2020 Elsevier Inc. All rights reserved.
引用
收藏
页数：13
相关论文
共 187 条
  • [1] The transcriptional PPARβ/δ network in human macrophages defines a unique agonist-induced activation state
    Adhikary, Till
    Wortmann, Annika
    Schumann, Tim
    Finkernagel, Florian
    Lieber, Sonja
    Roth, Katrin
    Toth, Philipp M.
    Diederich, Wibke E.
    Nist, Andrea
    Stiewe, Thorsten
    Kleinesudeik, Lara
    Reinartz, Silke
    Mueller-Bruesselbach, Sabine
    Mueller, Rolf
    [J]. NUCLEIC ACIDS RESEARCH, 2015, 43 (10) : 5033 - 5051
  • [2] Desnutrin/ATGL Is Regulated by AMPK and Is Required for a Brown Adipose Phenotype
    Ahmadian, Maryam
    Abbott, Marcia J.
    Tang, Tianyi
    Hudak, Carolyn S. S.
    Kim, Yangha
    Bruss, Matthew
    Hellerstein, Marc K.
    Lee, Hui-Young
    Samuel, Varman T.
    Shulman, Gerald I.
    Wang, Yuhui
    Duncan, Robin E.
    Kang, Chulho
    Sul, Hei Sook
    [J]. CELL METABOLISM, 2011, 13 (06) : 739 - 748
  • [3] Fatty acid metabolic reprogramming via mTOR-mediated inductions of PPARγ directs early activation of T cells
    Angela, Mulki
    Endo, Yusuke
    Asou, Hikari K.
    Yamamoto, Takeshi
    Tumes, Damon J.
    Tokuyama, Hirotake
    Yokote, Koutaro
    Nakayama, Toshinori
    [J]. NATURE COMMUNICATIONS, 2016, 7
  • [4] PPAR-γ agonists inhibit toll-like receptor-mediated activation of dendritic cells via the MAP kinase and NF-κB pathways
    Appel, S
    Mirakaj, V
    Bringmann, A
    Weck, MM
    Grünebach, F
    Brossart, P
    [J]. BLOOD, 2005, 106 (12) : 3888 - 3894
  • [5] The Peroxisome Proliferator-Activated Receptor γ Agonist Rosiglitazone Ameliorates Murine Lupus by Induction of Adiponectin
    Aprahamian, Tamar
    Bonegio, Ramon G.
    Richez, Christophe
    Yasuda, Kei
    Chiang, Lo-Ku
    Sato, Kaori
    Walsh, Kenneth
    Rifkin, Ian R.
    [J]. JOURNAL OF IMMUNOLOGY, 2009, 182 (01) : 340 - 346
  • [6] The protective effects of β-caryophyllene on LPS-induced primary microglia M1/M2 imbalance: A mechanistic evaluation
    Askari, Vahid Reza
    Shafiee-Nick, Reza
    [J]. LIFE SCIENCES, 2019, 219 : 40 - 73
  • [7] Auwerx J, 1999, CELL, V97, P161
  • [8] PPAR dual agonists: Are they opening Pandora's box?
    Balakumar, Pitchal
    Rose, Madhankumar
    Ganti, Subrahmanya S.
    Krishan, Pawan
    Singh, Manjeet
    [J]. PHARMACOLOGICAL RESEARCH, 2007, 56 (02) : 91 - 98
  • [9] Balint B. L., 2006, Endocrine Metabolic & Immune Disorders-Drug Targets, V6, P33
  • [10] PPARγ is required for placental, cardiac, and adipose tissue development
    Barak, Y
    Nelson, MC
    Ong, ES
    Jones, YZ
    Ruiz-Lozano, P
    Chien, KR
    Koder, A
    Evans, RM
    [J]. MOLECULAR CELL, 1999, 4 (04) : 585 - 595
12345678910